| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/17/2002 | EP1196599A2 Maize dna ligase ii orthologue and uses thereof |
| 04/17/2002 | EP1196598A1 Dsp-3 dual-specificity phosphatase |
| 04/17/2002 | EP1196597A2 Linoleate isomerase |
| 04/17/2002 | EP1196586A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 04/17/2002 | EP1196585A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 04/17/2002 | EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196570A2 Human polypeptides and methods for the use thereof |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196566A1 Expression vectors and methods |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196564A2 Atherosclerosis-associated genes |
| 04/17/2002 | EP1196561A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196554A1 Methods of cloning and producing fragment chains with readable information content |
| 04/17/2002 | EP1196553A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel dnd genes; regulators of plant disease resistance and cell death |
| 04/17/2002 | EP1196551A1 Electrical impedance tomography to control electroporation |
| 04/17/2002 | EP1196549A1 Controlled electroporation and mass transfer across cell membranes |
| 04/17/2002 | EP1196544A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/17/2002 | EP1196543A2 Treatment of dendritic cells for induction of immune tolerance |
| 04/17/2002 | EP1196541A2 Storage of microorganisms, cells and tissue |
| 04/17/2002 | EP1196540A2 Scaffold matrix and tissue maintaining systems |
| 04/17/2002 | EP1196448A2 Homomeric and heteromeric ampa receptors |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196439A2 Compounds exhibiting an antibiotic activity |
| 04/17/2002 | EP1196426A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196153A2 Process for the improvement of spermatozoa fertilization activity |
| 04/17/2002 | EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 04/17/2002 | EP1121421A4 Materials and methods for the modification of plant lignin content |
| 04/17/2002 | EP1107661A4 Plant fatty acid desaturase promoters |
| 04/17/2002 | EP0852627A4 Cell death protein |
| 04/17/2002 | EP0794790B1 Localized delivery of factors enhancing survival of transplanted cells |
| 04/17/2002 | EP0688196B1 Ported tissue implant systems |
| 04/17/2002 | EP0660664B1 Preserved, non-infectious control cells for use in the identification of a disease through blood testing |
| 04/17/2002 | EP0607178B1 Methods for the isolation and fusion of cells |
| 04/17/2002 | CN1345375A Streptococcus pneumoniae antigens |
| 04/17/2002 | CN1345374A HER-2/neu fusion proteins |
| 04/17/2002 | CN1345372A Transgenic plant resistant to mycotoxins and methods |
| 04/17/2002 | CN1345370A Compartmentalization of recombinant polypeptides in host cells |
| 04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 04/17/2002 | CN1345330A Pigment protein from coral tissue |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/17/2002 | CN1345242A Method for treatment of leukaemia |
| 04/17/2002 | CN1345234A Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
| 04/17/2002 | CN1083012C Process for producing taxanes diterpene |
| 04/17/2002 | CN1083011C Method for obtaining high-production culture cells of taxanes diterpene |
| 04/17/2002 | CN1083010C Process for producing taxues alkane diterpene |
| 04/16/2002 | US6372967 Plants with modified stamen cells |
| 04/16/2002 | US6372963 Cocultivating a culture of untransformed monocotyledonous plant cells with an agrobacterium strain, dna fragment under conditions in which the dna fragment is taken up by the untransformed cells and is stably integrated in genome |
| 04/16/2002 | US6372960 Barstar gene |
| 04/16/2002 | US6372959 Expression vector of a mud loach growth hormone gene |
| 04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
| 04/16/2002 | US6372956 Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor |
| 04/16/2002 | US6372890 Water-soluble polypeptides |
| 04/16/2002 | US6372711 Receptor binding assay using polypeptide have contiguous sequence of extracellular domain or polypeptide mutein genetically engineered by insertion, deletion, or replacement |
| 04/16/2002 | US6372501 Glucose responsive β-cell line |
| 04/16/2002 | US6372495 Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372493 Hormone-secreting cells maintained in long-term culture |
| 04/16/2002 | US6372490 Nucleic acid encoding the MDM interacting protein |
| 04/16/2002 | US6372488 AMPA-binding human GluR4 receptors |
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372482 Device and method for performing a biological modification of a fluid |
| 04/16/2002 | US6372480 Pesticidal proteins |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372471 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372456 In diagnosis methods for detecting central nervous system and immune system-related disorders and in therapy |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372438 Obtaining transformed mammalian cells comprising a recombinant nucleic acid encoding a hpdgf-r polypeptide; incubating transformed mammalian cells with compound, and incubating witout compound; comparing activation in test cells |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372422 Creating superovulation in non-human female mammal to create eggs by using an ovulatory pharmaceutical; determining sex of sperm cell of male mammal; sorting according to sex of sperm cells; inserting into uterus; fertilization to produce embryos |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372215 Monoclonal antibodies to human CD6 |
| 04/16/2002 | US6372214 Antibodies specific for native PrPSc |
| 04/16/2002 | US6372212 Chitinase materials and methods |
| 04/16/2002 | US6372210 Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free medium |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | CA2235752C Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products |
| 04/11/2002 | WO2002029410A2 Cells having a spectral signature, and methods of preparation and use thereof |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
| 04/11/2002 | WO2002029074A2 Genetic immunisation against cervical carcinoma |
| 04/11/2002 | WO2002029068A2 Virus-based amplification vector for plants |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002029064A2 Method for establishing germ cell-specific gene expression |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |